DocMorris AG (ZRSEF) Q4 2025 Earnings Call Transcript

SA Transcripts159.1K FollowersFollow5ShareSaveComments DocMorris AG (ZRSEF) Q4 2025 Earnings Call March 18, 2026 8:00 PM EDT Company Participants Walter Hess - Head of Germany, CEO & Member of Executive BoardDaniel Wüest - CFO & Member of Executive Board Conference Call Participants Laura Pfeifer-Rossi - Octavian AG, Research DivisionUrs Kunz - Research Partners AGSibylle Bischofberger FrickGian Werro - Zürcher Kantonalbank, Research DivisionJan Koch - Deutsche Bank AG, Research Division Presentation Walter HessHead of Germany, CEO & Member of Executive Board So good morning, everybody, here in Zurich and at the webcast. It's a pleasure for us to present our full year results 2025. With me today is Daniel Wuest, our CFO. My name is Walter Hess. I'm CEO. Let's go straight to the highlights of 2025. We delivered on our promises, and we met the financial targets 2025. We achieved 11.1% of revenue growth and minus 48% adjusted EBITDA. And with that, we achieved our guidance. The growth of Rx was 33.2% and of non-Rx, 7.1%. The digital services with a growth of 110%, so a remarkable growth rate again and a significant profitability contribution, it's a contribution margin free, which is more than 50% already of the total company. Our AI Health Companion, which we have started to launch in October last year as a beta version in our app has been adopted really very fast. Already every third app user is utilizing this AI health assistant. And with the strong liquidity position of CHF 160 million by end of the year, we are very confident to execute in 2026 and 2027 according to our plans. We are fully aware of the challenging and also critical market environment. However, we today focus on the future on our successful transition and on our path to breakeven and to cash generation. We do that by giving you an